Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation

SIMPLE SUMMARY: Pancreatic cancer is an aggressive disease characterized by its invasiveness, rapid progression, and resistance to conventional therapy. There is a need to identify new molecules to improve current therapies. The aim of this study was to analyze how the pancreatic cancer cells react...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalabi-Dchar, Mounira, Cruz, Elisabeth, Mertani, Hichem C., Diaz, Jean-Jacques, Courty, José, Cascone, Ilaria, Bouvet, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508287/
https://www.ncbi.nlm.nih.gov/pubmed/34638443
http://dx.doi.org/10.3390/cancers13194957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508287/
https://www.ncbi.nlm.nih.gov/pubmed/34638443
http://dx.doi.org/10.3390/cancers13194957

Ejemplares similares